p-Cresol and C. difficile: A Love-Hate Story Revealed by Raman Spectroscopy
- PMID: 40698931
- PMCID: PMC12332841
- DOI: 10.1021/acs.analchem.5c02927
p-Cresol and C. difficile: A Love-Hate Story Revealed by Raman Spectroscopy
Abstract
Clostridioides difficile is known to produce p-cresol, a phenolic compound with selective antimicrobial properties, which may contribute to its competitive advantage within the gut microbiome. In this study, we investigated the interaction between Clostrioides difficile and Escherichia coli in coculture to assess the role of p-cresol in modulating interspecies dynamics. Raman spectroscopy was employed as a label-free, nondestructive analytical technique to profile the molecular signatures of both species in mono- and coculture. Excitation wavelengths at 244 and 532 nm were used to enhance complementary vibrational features, including those associated with aromatic compounds like p-cresol. Our results demonstrate distinct spectral changes in coculture conditions suggesting the involvement of p-cresol and its impact on the biochemical composition of E. coli. This dual-wavelength Raman approach offers a powerful means of characterizing microbial interactions and identifying metabolic markers that may drive microbial competition and survival.
Figures







Similar articles
-
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4. Cochrane Database Syst Rev. 2017. PMID: 29257353 Free PMC article.
-
Genomic insights into tigecycline non-susceptibility in Clostridioides difficile: the role of the Tet P determinant and efflux mechanisms.BMC Microbiol. 2025 Jul 7;25(1):421. doi: 10.1186/s12866-025-04143-9. BMC Microbiol. 2025. PMID: 40624625 Free PMC article.
-
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2. Cochrane Database Syst Rev. 2023. PMID: 37096495 Free PMC article.
-
Clostridioides difficile-mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation.mSphere. 2024 Jun 25;9(6):e0008124. doi: 10.1128/msphere.00081-24. Epub 2024 Jun 5. mSphere. 2024. PMID: 38837404 Free PMC article.
-
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.Cochrane Database Syst Rev. 2013 May 31;(5):CD006095. doi: 10.1002/14651858.CD006095.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Dec 19;12:CD006095. doi: 10.1002/14651858.CD006095.pub4. PMID: 23728658 Updated.
References
-
- Di Bella S., Sanson G., Monticelli J., Zerbato V., Principe L., Giuffrè M., Pipitone G., Luzzati R.. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clin. Microbiol. Rev. 2024;37(2):e00135–e00123. doi: 10.1128/cmr.00135-23. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources